Pfizer, Inc.

You’re probably already familiar with one of this pharmaceuticals giant’s newest products; Pfizer’s COVID-19 vaccine is the most popular across Europe and the US and has been administered to hundreds of millions of people on every continent. Pfizer makes a lot more than just a vaccine though, and other ‘blockbuster’ drugs contribute to their record profits.

Founded in Brooklyn in 1849 by Charles Pfizer and his cousin Charles Erhart, recent immigrants to the US from Germany, Pfizer initially found success manufacturing antiparasitic drugs and citric acid. By purchasing adjacent properties, they eventually founded a major chemicals plant and expanded their product range. By the turn of the 20th century, the company was achieving sales of $3 million, over 91 million in 2021 dollars. After Charles Pfizer’s death in 1906, his youngest son Emile took the reins and focused the company on innovative methods of chemical production.

During WWII, huge demand for penicillin-based antibiotics saw Pfizer working closely with the American government, setting the stage for their post-war expansion into the global market. The 1970s saw a renewed focus on their research and development efforts, which came to fruition in the 1980s with successful anti-inflammatory drugs and blood pressure medications. The statin (an anti-cholesterol drug) atorvastatin became the biggest selling prescription drug of all time after its launch in 1997. More recently, Pfizer’s COVID vaccine has contributed billions in additional sales, after a very successful 2020 which saw $42 billion in revenue across the company. Other strong revenue generators include tafamidis, which treats a rare heart condition and was recently approved for use in the US and Japan. Pfizer has faced legal challenges for its marketing practices, including $2 billion in penalties in 2009, and it has had mergers blocked by both the British and American governments in the last ten years. With over 100,000 employees, Pfizer is one of the largest pharmaceutical companies in the world.

Pfizer has been a publicly traded company for nearly half its 200-year history, first listing on the New York Stock Exchange in 1942. Shares started trading at $24.75 apiece in what was one of the largest IPOs of 1942. In 2004, Pfizer became one of the constituent stocks of the Dow Jones Industrial Average. Accordingly, the stock is popular with major institutional investors, with Vanguard and State Street the largest single owners.

SaxotraderGO HERO

Invest in Pfizer, Inc. stocks in SaxoTraderGO

Do you want more information about investing or investing in the Pfizer, Inc. stock? Then open an account with Saxo Bank now. You will also receive technical analysis, expert insights, market news and much more.

SaxotraderGO HERO

See stock analyzes and key figures Pfizer, Inc.

Get access to clear analyzes and key figures for the Pfizer, Inc. stock. At Saxo Bank, you will find expert insights from our own SaxoStrats, view market analysts as well as technical analysis, all gathered in one place.

Before investing in individual stocks, it is recommended to make a thorough analysis. Investing carries risks, your investment can lose value.

Stocks illustration_769x385_v2

*The illustration is used as an example only. For the most up-to-date information on this instrument, existing customers should use the trading platform.

Gainers
Instrument
Visa Inc.
3V64:xetr . EUR
Nvidia Corp.
NVDA:xmil . EUR
Vestas Wind Systems A/S
VWS:xcse . DKK
NVIDIA Corp.
NVD:xetr . EUR
Thomson Medical Group Ltd
A50:xses . SGD
Instrument

“Market movers” show you the biggest price fluctuations across selected markets. Data is delayed up to 30 minutes. See the full disclaimer for more information.

Invest in popular stocks, in addition to Pfizer, Inc.

Invest in popular stocks, in addition to Pfizer, Inc.

At Saxo Bank, you can trade over 19,000 stocks. The large selection allows you to find exactly what you need, from niche small-cap options to the well-known large companies with high market caps. See a selection of the most popular stocks you can invest in on our user-friendly platforms, SaxoTraderGO.

Find your next investment

Are you looking for inspiration? Our SaxoStrats provide daily analysis across asset classes including stocks that can help you identify your next opportunity. If you want to invest in a specific market trend, you can select stocks based on different themes. Use our Stock Screener to filter stocks by sector, market, investment theme and more.
Find our investment
Account-overview-front-desktop

Should our experts invest for you?

Do not have the time, knowledge or energy to make your own investments? So let our independent experts navigate the market and manage your investments for you.

Frequently asked questions about Pfizer, Inc.

Find quick answers to your questions about trading Pfizer, Inc. at Saxo Bank. We have gathered answers to the questions we most often get from new and existing customers.

To buy shares in Pfizer, log in to one of our platforms - SaxoInvestor, SaxoTraderGO or SaxoTraderPRO - and search for the ticker ‘PFE’. If you don’t have an account, you can create one by clicking here.

Check the current price on your account by searching for Pfizer. Select the trade ticket, click on the ‘I’ icon and then navigate to ‘Trading Rates’ to see transaction costs. No account? No problem – just click here to open a Saxo account now.

On our platforms there is a wide range of financial information to help you decide if Pfizer is the right investment for you. There you will find stock analysis, financial reports, and current and historical price charts. You can open an account here.

Pfizer is a reliable payer of a quarterly dividend, although this remains discretionary and is never guaranteed. You can find full price and dividend history by logging on to your trading platform and searching for Pfizer.

You can see how Pfizer shares have performed in the past by logging in to your trading platform account to see detailed price charts and historical financial data. If you don’t have an account, you can open one by clicking here.

Information on this page is not intended for investment advice or as an individual recommendation for trading. Reward to the author of this article was / is not related to his / her specific recommendation or views. Although Saxo Bank carefully collects and maintains these pages using reliable sources, Saxo Bank can not guarantee that this information is correct, complete or current. If you use this information without verification, it is at your own expense and risk. No rights can be inferred from the information on these pages. Investment involves risks. Your investment may be worth less. Read more information about the specific product risks on the product pages.

Saxo Bank A/S (Headquarters)
Philip Heymans Alle 15
2900
Hellerup
Denmark

Contact Saxo

Select region

International
International

Trade responsibly
All trading carries risk. Read more. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more

This website can be accessed worldwide however the information on the website is related to Saxo Bank A/S and is not specific to any entity of Saxo Bank Group. All clients will directly engage with Saxo Bank A/S and all client agreements will be entered into with Saxo Bank A/S and thus governed by Danish Law.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.